Prescription Drug Diversion and Counterfeiting: Hearings Before the Subcommittee on Oversight and Investigations of the Committee on Energy and Commerce, House of Representatives, Ninety-ninth Congress, First-[second] Session, Part 1
United States. Congress. House. Committee on Energy and Commerce. Subcommittee on Oversight and Investigations
U.S. Government Printing Office, 1986 - Drug control
What people are saying - Write a review
We haven't found any reviews in the usual places.
Other editions - View all
activity adulterated Allen American Association believe Bilirakis Board buying called Chairman committee companies concern consumers continuing correct cost counterfeit criminal Customs deal dispensing distribution don't drug diversion effective enforcement expired fact Federal Florida going hearings Helterhoff hospitals illegal important indicated institutions internal invoice involved issue Kowitt license look manager manufacturers medication merchandise Miami Michigan nonprofit obtained Okay operation packaging Panama patient pharmaceuticals pharmacists pharmacy physicians pills practice prescription drugs problem profit purchase question received record regulations representatives retail samples sell shipped Sikorski sold staff statement stored subcommittee tablets talking Thank thing tion United wholesalers Wyden Yeah Yes Yes
Page 458 - On behalf of the Officers, Executive Committee, and members of the National Association of Retail Druggists, we thank you for the opportunity to appear and continue to participate in the formulation of Medicare Part B outpatient prescription drug coverage . Mr.
Page 455 - ... so as a result of the passage of the Act. These institutions, typified by almshouses or pauper hospitals, were supported by subscription and were making their services available to people who could not pay for the services. Today, nonprofits that are engaging in commercial activities with for-profit firms that pay Federal, state, and local taxes for the privilege of doing business, claim the protection of that exemption. That claim flies in the face of the purpose of the exemption and their method...
Page 417 - BEFORE THE SUBCOMMITTEE ON HEALTH AND SCIENTIFIC RESEARCH OF THE SENATE COMMITTEE ON HUMAN RESOURCES...
Page 422 - Greenspan, we will make a copy of your prepared remarks a part of our hearing record in their entirety and if you...
Page 507 - The committee now stands adjourned. (Whereupon, at 2:58 pm, the subcommittee was adjourned.) (The following material was submitted for the record :) STATEMENT OF SENATOR THOMAS J.
Page 453 - NARD has long been acknowledged as the sole advocate for this vital component of the free enterprise system. NARD members are primarily family businesses.
Page 302 - I wish to thank you, Mr. Chairman, and the members of your committee, for the opportunity to...
Page 162 - Administration, the information delated does not fall within the scope of your request and, in any case, is not required to be disclosed under the Freedom of Information Act. If, however, you do desire to review the deleted material, please make an additional request. If the agency should then deny you this Information, you would have the right to appeal such denial to the Department of Health, Education, and Welfare. Any letter of denial will tell you how Jo nake this appeal.
Page 399 - APhA is the national professional society of pharmacists, representing the third largest health profession that comprises more than 150,000 pharmacy practitioners, pharmaceutical scientists and pharmacy students. Since its founding in 1852, APhA has been a leader in the professional and scientific advancement of pharmacy and in safeguarding the well-being of the individual patient.